微信关注
Total item
Cart Subtotal
￥ 0.00 CETP
| Catalog No. | Inhibitor Name | CETP |
|---|---|---|
| A11084 | Anacetrapib (MK-0859) | *** |
| A11242 | Torcetrapib (CP-529414) | ** |
| A11213 | JTT-705 (Dalcetrapib) | * |
| A11397 | Evacetrapib (LY2484595) | **** |
Notes:
1.Hover mouse over "" to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of "" is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.
6 个项目
每页
-
CKD-519
Catalog No. A18873 CETP inhibitorCKD-519 is a selective and potent cholesteryl ester transfer protein (CETP) inhibitor being developed for the treatment of dyslipidemia to raise high-density lipoprotein cholesterol. Single doses of CKD-519 up to 400 mg were well tolerated and showed potent inhibition of CETP activity. 了解更多 -
Anacetrapib (MK-0859)
Catalog No. A11084 CETP 抑制剂Anacetrapib (MK-0859)是一种有效的，选择性，可逆的rhCETP和突变CETP(C13S)抑制剂，IC50分别为7.9 nM和11.8 nM，提高HDL-C，降低LDL-C，不提高醛固酮和血压。 了解更多 -
JTT-705 (Dalcetrapib)
Catalog No. A11213 CETP 抑制剂JTT-705 (Dalcetrapib)是一种CETP抑制剂，抑制CETP是增加HDL-胆固醇并可能减少动脉粥样硬化的目标。 了解更多 -
Torcetrapib (CP-529414)
Catalog No. A11242 -
Evacetrapib (LY2484595)
Catalog No. A11397 CETP 抑制剂Evacetrapib (LY2484595)是一种强效选择性CETP抑制剂，IC50为5.5 nM，可在不增加醛固酮或血压的情况下升高HDL胆固醇。 了解更多
6 个项目
每页
FILTER BY:
购物选项
- 作用机制
-
- Inhibitor (抑制剂) (6)
- 靶点
-
- CETP (4)
ADOOQ 产品质量保证
We promise all products to perform as described.